Orchid Pharma reports consolidated net loss of Rs 30.90 crore in the June 2021 quarter
Sales decline 22.53% to Rs 92.31 crore
Net Loss of Orchid Pharma reported to Rs 30.90 crore in the quarter ended June 2021 as against net loss of Rs 22.66 crore during the previous quarter ended June 2020. Sales declined 22.53% to Rs 92.31 crore in the quarter ended June 2021 as against Rs 119.16 crore during the previous quarter ended June 2020. ParticularsQuarter EndedJun. 2021Jun. 2020% Var.Sales92.31119.16 -23 OPM %-3.2816.20 -PBDT-10.796.99 PL PBT-30.90-22.66 -36 NP-30.90-22.66 -36Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content